Prelude Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,998	Closed	-$422K	–	1186
2025 Q4	$422K	Buy	25,998 +7,362	+40%	+$120K	0.03%	612
2025 Q3	$279K	Buy	+18,636	New	+$227K	0.02%	769
2023 Q4	–	Sell	-13,156	Closed	-$71.7K	–	1109
2023 Q3	$71.7K	Sell	13,156 -18,648	-59%	-$123K	0.01%	1017
2023 Q2	$213K	Sell	31,804 -3,650	-10%	-$27.1K	0.02%	821
2023 Q1	$313K	Buy	35,454 +12,776	+56%	+$113K	0.02%	630
2022 Q4	$173K	Sell	22,678 -80,138	-78%	-$623K	0.01%	1000
2022 Q3	$732K	Buy	102,816 +8,591	+9%	+$80.9K	0.04%	516
2022 Q2	$762K	Sell	94,225 -50,957	-35%	-$448K	0.04%	622
2022 Q1	$2.02M	Buy	+145,182	New	+$2.28M	0.09%	330
2021 Q4	–	Sell	-6,489	Closed	-$221K	–	1971
2021 Q3	$221K	Sell	6,489 -1,361	-17%	-$49.2K	0.01%	1301
2021 Q2	$321K	Sell	7,850 -13,043	-62%	-$507K	0.02%	1163
2021 Q1	$841K	Buy	20,893 +15,781	+309%	+$854K	0.06%	662
2020 Q4	$302K	Buy	5,112 +3,745	+274%	+$193K	0.02%	912
2020 Q3	$66K	Buy	+1,367	New	+$57.5K	0.01%	1044
2019 Q4	–	Sell	-143	Closed	-$4K	–	1881
2019 Q3	$4K	Buy	+143	New	+$5.84K	﹤0.01%	1575